Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19 | Signal Transduction and Targeted Therapy
Frontiers | ACE/ACE2 Ratio: A Key Also in 2019 Coronavirus Disease (Covid-19)?
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19 | Critical Care | Full Text
The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19: Molecular Therapy - Methods & Clinical Development
COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection | SpringerLink
Role of angiotensin-converting enzyme 2 in neurodegenerative diseases during the COVID-19 pandemic | Aging
Molecules | Free Full-Text | The Two-Way Switch Role of ACE2 in the Treatment of Novel Coronavirus Pneumonia and Underlying Comorbidities
ACE and ACE2 in Inflammation: A Tale of Two Enzymes | Bentham Science
IJMS | Free Full-Text | COVID-19 and RAS: Unravelling an Unclear Relationship
The Impact of ACE and ACE2 Gene Polymorphisms in Pulmonary Diseases Including COVID-19 | In Vivo
ACE2 as a potential therapeutic target for pandemic COVID-19 - RSC Advances (RSC Publishing)
Allosteric Site of ACE-2 as a Drug Target for COVID-19 | ACS Pharmacology & Translational Science
ACE2 as a potential therapeutic target for pandemic COVID-19 - RSC Advances (RSC Publishing) DOI:10.1039/D0RA08228G
SARS-CoV-2 receptor |Human ACE2-Fc | InvivoGen
Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications - ScienceDirect
SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy - eBioMedicine
Angiotensin II regulation of angiotensin‐converting enzymes in spontaneously hypertensive rat primary astrocyte cultures - Gowrisankar - 2016 - Journal of Neurochemistry - Wiley Online Library
Leichtes Spiel für SARS-CoV-2?
Frontiers | ACE2, Much More Than Just a Receptor for SARS-COV-2
SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy